Download PDF
Thromb Haemost 1987; 57(02): 242
DOI: 10.1055/s-0038-1651109
Letters to the Editor
Schattauer GmbH Stuttgart

Antithrombotic Action of Hepatic Triglyceride Lipase - Fact or Fiction -Rejoinder

Trevor W Barrowcliffe
Division of Blood Products, National Institute for Biological Standards and Control, Holly Hill, Hampstead, London NW3 6RB, U.K.
› Author Affiliations
Further Information

Publication History

Received 02 February 1987

Accepted after revision 04 February 1987

Publication Date:
28 June 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Barrowcliffe TW, Gray E, Merton RE, Dawes J, Jennings CC, Hubbard AR, Thomas DP. Anticoagulant activities of pentosan polysulphate (Hémoclar) due to release of hepatic triglyceride lipase (HTGL). Thromb Haemostas 1986; 56: 202-206
    PubMedGoogle Scholar
  • 2 Williams SP, Barrowcliffe TW. The effects of post-heparin plasma lipases on anti-Xa clotting activity. Thromb Res 1985; 37: 371-377
    CrossrefPubMedGoogle Scholar
  • 3 Eggleton CA, Barrowcliffe TW, Merton RE, Thomas DP. In vitro and in vivo studies of the anti-Xa activity of heparin. Thromb Res 1981; 24: 318-328
    PubMedGoogle Scholar
  • 4 Denson K WE, Bonnar J. The measurement of heparin: a method based on the potentiation of anti-Factor Xa. Thrombos Diathes Haemorrh 1973; 30: 471-479
    PubMedGoogle Scholar
  • 5 Gray E, Bengtsson-Olivecrona G, Olivecrona T, Barrowcliffe TW. The anti-Xa activity of human hepatic triglyceride lipase (HGTL). J Lab Clin Med. 1987 (in press)
    PubMedGoogle Scholar
  • 6 Yin ET, Wessler S, Butler JV. Plasma heparin: a unique, practical, submicrogram-sensitive assay. J Lab Clin Med 1977; 81: 298-310
    PubMedGoogle Scholar